Select Equity Group’s Core Laboratories CLB Stock Holding History

Select Equity Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,452,751	Closed	-$54.7M	–	117
2019 Q4	$54.7M	Sell	1,452,751 -89,689	-6%	-$4.03M	0.35%	58
2019 Q3	$71.9M	Buy	1,542,440 +371,303	+32%	+$17.3M	0.49%	49
2019 Q2	$61.2M	Buy	1,171,137 +239,657	+26%	+$14.1M	0.42%	51
2019 Q1	$64.2M	Sell	931,480 -23,565	-2%	-$1.58M	0.43%	51
2018 Q4	$57M	Buy	955,045 +533,085	+126%	+$46M	0.43%	51
2018 Q3	$48.9M	Buy	421,960 +137,663	+48%	+$15.5M	0.36%	58
2018 Q2	$35.9M	Sell	284,297 -15,170	-5%	-$1.85M	0.29%	62
2018 Q1	$32.4M	Buy	299,467 +121,786	+69%	+$13.5M	0.27%	61
2017 Q4	$19.5M	Buy	+177,681	New	+$17.7M	0.15%	73
2014 Q4	–	Sell	-158,379	Closed	-$23.2M	–	106
2014 Q3	$23.2M	Buy	158,379 +156,573	+8,670%	+$24.2M	0.24%	70
2014 Q2	$302K	Buy	+1,806	New	+$321K	﹤0.01%	104

Other funds holding CLB

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Select Equity Group's CLB Position: Q1 2020 in Review

Select Equity Group sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 1,452,751 shares — an estimated $54.7M sold.

Select Equity Group first reported a position in CLB in Q2 2014 and held it in 11 quarters. The position peaked at $71.9M in Q3 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Select Equity Group reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Select Equity Group sold 1,452,751 Core Laboratories shares in Q1 2020, an estimated $54.7M.
Select Equity Group first reported a position in Core Laboratories in Q2 2014 and held it in 11 quarters.
Select Equity Group's Core Laboratories position peaked at $71.9M in Q3 2019.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Select Equity Group's 13F filing for Q1 2020, filed 15 May 2020.